Table 1.
Absorption and Metabolism of Vortioxetine10
Oral bioavailability | 75% |
Time to peak plasma concentration | 7–11 hours |
Metabolic pathway | CYP2D6, CYP3A4/5, CYP2C19, CYP2C9, CYP2A6, CYP2C8, and CYP2B6, with subsequent glucuronic acid conjugation |
Half-life | Approximately 66 hours |
Protein binding | 98% |
Elimination | Approximately 59% urine and 26% feces |